Skip to main content

Hindcon Chemicals Ltd Shares List at the NSE Emerge



Script lists at 20% premium
IPO subscribed 132 times
The Equity Shares of Hindcon Chemicals Ltd, engaged in manufacturing wide range of chemical products, listed today at the NSE Emerge Platform. The script made a strong debut and surged 20 percent, post the listing. Stock opened at Rs 33.60 against the IPO price of Rs 28 a share.

The public issue which was open for subscription from 26 February to 28 February 2018 raised 7.73 Cr through offering 27, 60,000 Equity Shares of face value of Rs. 10 each for cash at price of Rs. 28 per Equity Share.  The net proceeds from the IPO will be utilized for meeting working capital requirements, general corporate and issue expenses. 

Mr. Sanjay Goenka, Managing Director and Promoter, Hindcon Chemicals Ltd said, “Having a company listed is significant milestone and we as a group are elated to have received such an overwhelming response to our maiden IPO. We thank all our investors and merchant banker for the support in making our IPO exceedingly successful”

The Lead Manager to the Issue Mr Gaurav Jain & Mr Prateek Jain, Directors, Hem Securities Ltd., said “We are delighted to have received such a prodigious investor response to Hindcon Chemicals IPO, which was attractively priced and pedantically marketed. The IPO received overwhelming response procuring subscription amount of over Rs 1022 crore as the issue overall subscribed 132.29 times. The HNI and Retail portion subscribed 154.85 and 124.18 times respectively. As a leading merchant banker in the SME IPO space, Hem Securities has been consistently acknowledged by BSE, NSE and independent agencies for our strong focus on fundamentally good quality companies that are poised for accelerated growth and long term wealth creation for the investors”

Hindcon Chemicals, incorporated in 1998, has been in the business of construction chemicals for the last 20 years. The Company has over 100 products in its portfolio with main foray into sodium silicate, waterproofing additives, plasticizers etc. The Company has its manufacturing facility located in Howrah which has an installed capacity of 30,000 MT per year. Company’s key product portfolio includes Protective waterproofing coatings, Sodium Silicates, Concrete & mortar admixtures, Epoxy grouts & mortars, Waterproofing compounds, Shot crete aids, Remover cleaning compounds, Sealants, Tile adhesives, among others.

Location: Mumbai, Maharashtra, India

Comments

Post a Comment

Popular posts from this blog

Country Delight Launches NMR-Tested Honey: The Gold Standard of Purity

  Country Delight continues strengthening its promise of delivering the best purity and quality by launching 100% Pure Farm Honey (NMR Tested) Country Delight, a trusted name in premium and natural essentials, has announced the launch of 100% Pure Farm Honey (NMR Tested). Country Delight’s Farm Honey is Nuclear Magnetic Resonance (NMR) tested by a certified lab in Germany, making it one of the most authentic and reliable kitchen ingredients available to Indian homes. It also undergoes rigorous testing on 36 quality parameters as per FSSAI standards, including physicochemical, antibiotic and microbial, to rule out the presence of added sugars. Honey is not just a natural sweetener; it is increasingly valued for its functional benefits. With Country Delight's NMR-tested honey, consumers can enjoy a product that supports wellness through its natural composition, which is rich in antioxidants and phytonutrients and offers advantages over refined sugars.  Adulteration with cheaper ...
Post a Comment
Read more

CARE Ratings shares list at 25% premium on NSE

Credit Analysis and Research Limited (  CARE ) has listed at Rs 940, a 25% premium against its issue price of Rs 750 per share on the National Stock Exchange (NSE). The stock hit a high of Rs 955 and low of Rs 930 so far. A combined 1.41 million shares have changed hands on the counter in opening deals on the NSE and BSE. CARE, the second-largest credit rating agency in India, has raised Rs 540 crore by issuing 7.2 million shares through initial public offer (IPO). The company has fixed the issue price at higher price band at Rs 700-750 per share. The IPO attracted bids for 245.56 million shares against 7.2 million shares on offer, translating to 34.11 times subscription, according to information available in basis of allotment.   The category reserved for qualified institutional buyers (QIBs) was subscribed 43 times, while non-institutional investor’s portion received 110 times subscription. Shares reserved for retail investors got subscribed 6.11 tim...
Post a Comment
Read more

Prachay Capital’s Public Issue of Secured NCDs Fully Subscribed at 113.36%

Prachay Capital Limited, an RBI-registered Non-Banking Financial Company – Investment and Credit Company (NBFC-ICC), has successfully closed its public issue of Secured, Rated, Redeemable Non-Convertible Debentures (NCDs) at 113.36% subscription, according to exchange data. The issue, which opened on February 28, 2025, on the Bombay Stock Exchange (BSE), aimed to raise Rs 50 crore (excluding the greenshoe option) and closed on March 13, 2025. With a BSE listing, this issue was open for subscription to retail investors, high-net-worth individuals (HNIs), institutional investors, and corporates. The maiden NCDs issue is scheduled to list on 24 March 2025.  Rated BBB-/Stable by CRISIL, these NCDs offer investors a 13% per annum return with monthly interest payouts, making them an attractive fixed-income opportunity. The proceeds will be deployed as per the company’s stated fund allocation plan. Fund Utilization: Minimum 75% for the purpose of onward lending, investments in current and...
Post a Comment
Read more